Gain direct insight into how leading pharma and biotech teams are advancing COPD pipelines, with case studies and discussions focused on biomarker-led trials, emerging biologics, and strategies to overcome translational and regulatory barriers.
Position your organisation alongside leading solution providers and engage directly with pharma and biotech teams actively advancing COPD pipelines, looking for partners to accelerate development.